MADISON, N.J. and BENTONVILLE, Ark. , June 26, 2017-- Quest Diagnostics (NYSE: DGX) and Wal-Mart Stores, Inc. (NYSE: WMT), announced they will be working together to help improve access to care and, over time, help lower costs for basic healthcare services.

The collaboration will initially launch with a select number of locations (approximately 15) in Walmart stores in Florida and Texas by the end of 2017. These co-branded sites will initially provide laboratory testing services. Over time, offerings are expected to expand to include other basic healthcare services.

'We are proud to expand consumer access to health care through our work with Walmart,' said Steve Rusckowski, Quest Diagnostics chairman, president and CEO. 'By providing laboratory testing and healthcare services where people also shop, we will make it easier for Walmart customers and their associates to get the quality diagnostic insights they need in convenient locations. We are excited to partner with Walmart, one of the world's leading businesses with a passion for improving the lives of Walmart's customers and associates.'

'At Walmart, we're not only focused on providing accessible, affordable healthcare, but also working to extend our offerings - truly making our stores a one-stop shop for our customers' everyday health and wellness needs,' said George Riedl,senior vice president and president, Walmart Health and Wellness. 'We look forward to working with Quest as we operate in an increasingly dynamic and consumer-centric health care environment.'

Quest has been a leader in the movement for consumer empowerment in healthcare. The company has been a strong advocate of the effort to provide patients with direct access to lab testing in Colorado and Missouri, as well as through its Sonora Quest Laboratories joint venture in Arizona. More than five million patients track and access their lab results and health data through its myQuest by Care360™patient portal and mobile app. Other consumer offerings include genotyping test services on behalf of AncestryDNA, a service that today identifies and quantifies an individual's ethnic origins based on results of DNA testing.

About Walmart
Walmart Stores, Inc. (NYSE: WMT) helps people around the world save money and live better - anytime and anywhere - in retail stores, online, and through their mobile devices. Each week, over 260 million customers and members visit our 11,695 stores under 59 banners in 28 countries and e-commerce websites in 11 countries. With fiscal year 2017 revenue of $485.9 billion, Walmart employs approximately 2.3 million associates worldwide. Walmart continues to be a leader in sustainability, corporate philanthropy and employment opportunity. Additional information about Walmart can be found by visiting http://corporate.walmart.com on Facebook at http://facebook.com/walmart and on Twitter at http://twitter.com/walmart.

About Quest Diagnostics
Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 43,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. www.QuestDiagnostics.com .

50th Anniversary: In 2017, Quest Diagnostics celebrates 50 years of life-changing results. To learn about our legacy of accomplishments and quest to improve healthcare in the future, visit www.QuestDiagnostics.com/50Years .

Quest Diagnostics Contacts:
Denny Moynihan (Media): 973-520-2800
Shawn Bevec (Investors): 973-520-2900

Walmart Contact:
Erin Hulliberger, Walmart Media Relations
1-800-331-0085
news.walmart.com/reporter

Quest Diagnostics Incorporated published this content on 26 June 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 26 June 2017 14:19:05 UTC.

Original documenthttp://ir.questdiagnostics.com/phoenix.zhtml?c=82068&p=irol-newsArticle&ID=2283130

Public permalinkhttp://www.publicnow.com/view/5CDD4AD7E3DFE31D88CA6FF77FE269AF12A9E7F9